SCHEMBL14217240

SCHEMBL14217240

Cc1cc(N)c(N)cc1N1CCC(C(F)(F)F)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
MAPT P10636 5/20 0.36
GAA P10253 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NR4A1 P22736 2/20 0.36
THRB P10828 1/20 0.36
PTK2B Q14289 1/20 0.36
USP2 O75604 1/20 0.36
CHRM3 P20309 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
HTT P42858 1/20 0.33
MAP4K4 O95819 1/20 0.33
PIK3CA P42336 2/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
MTOR P42345 1/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25191149 0.92 HSD17B10 (0.36) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL14217241 0.82 MAPT (0.48) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL15033706 0.82 AR (0.34) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL10036396 0.81 MAPT (0.59) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL9899457 0.81 ALDH1A1 (0.43) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL9900024 0.81 SCN10A (0.35) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL30279094 0.80 ALDH1A1 (0.43) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL25207396 0.80 ALDH1A1 (0.43) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL25199801 0.79 ALDH1A1 (0.42) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL31053484 0.79 ALDH1A1 (0.42) ALDH1A1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822498-B2 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof CONCERT PHARMACEUTICALS, INC. (US) 2014-09-02 US disclosed
US-8466186-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-18 US disclosed
US-20120309738-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309738-A1 NOVEL COMPOUNDS PTGER1, PTGS1, PTGES ALDH1A1 140/4885MAPT 4308/4885GAA 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.